nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexbrompheniramine—KCNH2—Potassium Channels—HCN3—Parkinson's disease	0.0499	0.0641	CbGpPWpGaD
Dexbrompheniramine—Captodiame—DRD3—Parkinson's disease	0.0461	0.208	CrCbGaD
Dexbrompheniramine—KCNH2—Potassium Channels—KCNJ4—Parkinson's disease	0.0321	0.0413	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.0309	0.0397	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.0234	0.0301	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—HCN3—Parkinson's disease	0.0218	0.028	CbGpPWpGaD
Dexbrompheniramine—Chlorphenamine—SLC6A3—Parkinson's disease	0.0194	0.0874	CrCbGaD
Dexbrompheniramine—Mepyramine—CYP2D6—Parkinson's disease	0.0189	0.0854	CrCbGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR1A—Parkinson's disease	0.0177	0.0228	CbGpPWpGaD
Dexbrompheniramine—Tripelennamine—CYP2D6—Parkinson's disease	0.0175	0.079	CrCbGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD1—Parkinson's disease	0.0171	0.022	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD3—Parkinson's disease	0.0166	0.0213	CbGpPWpGaD
Dexbrompheniramine—Carbinoxamine—CYP2E1—Parkinson's disease	0.0163	0.0736	CrCbGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR7—Parkinson's disease	0.015	0.0193	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—DRD2—Parkinson's disease	0.015	0.0193	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.0149	0.0192	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.0146	0.0188	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.0144	0.0185	CbGpPWpGaD
Dexbrompheniramine—Brompheniramine—CYP2E1—Parkinson's disease	0.0141	0.0637	CrCbGaD
Dexbrompheniramine—KCNH2—Neuronal System—KCNJ4—Parkinson's disease	0.014	0.018	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.0139	0.0179	CbGpPWpGaD
Dexbrompheniramine—Tolterodine—CYP2D6—Parkinson's disease	0.0139	0.063	CrCbGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.0126	0.0162	CbGpPWpGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.0126	0.0162	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—DLG1—Parkinson's disease	0.0121	0.0156	CbGpPWpGaD
Dexbrompheniramine—Carbinoxamine—CYP2D6—Parkinson's disease	0.012	0.054	CrCbGaD
Dexbrompheniramine—Promazine—DRD1—Parkinson's disease	0.012	0.054	CrCbGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.011	0.0141	CbGpPWpGaD
Dexbrompheniramine—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.0105	0.0135	CbGpPWpGaD
Dexbrompheniramine—Brompheniramine—CYP2D6—Parkinson's disease	0.0104	0.0468	CrCbGaD
Dexbrompheniramine—Chlorphenamine—CYP2D6—Parkinson's disease	0.0102	0.0459	CrCbGaD
Dexbrompheniramine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—Parkinson's disease	0.00988	0.0127	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00984	0.0126	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.0098	0.0126	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIK1—Parkinson's disease	0.00948	0.0122	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00947	0.0122	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00932	0.012	CbGpPWpGaD
Dexbrompheniramine—Orphenadrine—CYP2E1—Parkinson's disease	0.00889	0.0402	CrCbGaD
Dexbrompheniramine—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00884	0.0113	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00847	0.0109	CbGpPWpGaD
Dexbrompheniramine—Promazine—DRD2—Parkinson's disease	0.00843	0.038	CrCbGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.0083	0.0107	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00815	0.0105	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIK2—Parkinson's disease	0.00806	0.0104	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC18A2—Parkinson's disease	0.00781	0.01	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00743	0.00954	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00726	0.00932	CbGpPWpGaD
Dexbrompheniramine—Diphenhydramine—CYP2D6—Parkinson's disease	0.0069	0.0312	CrCbGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00688	0.00884	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00664	0.00853	CbGpPWpGaD
Dexbrompheniramine—Promazine—HTR2A—Parkinson's disease	0.00651	0.0294	CrCbGaD
Dexbrompheniramine—KCNH2—Neuronal System—CHRNA4—Parkinson's disease	0.00618	0.00794	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.006	0.00771	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00589	0.00757	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—Parkinson's disease	0.00578	0.00743	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—HSPA8—Parkinson's disease	0.00566	0.00727	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00561	0.00721	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.00553	0.0071	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00537	0.0069	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—DLG4—Parkinson's disease	0.00531	0.00683	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—GRIN2B—Parkinson's disease	0.00519	0.00667	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—SLC6A3—Parkinson's disease	0.00512	0.00658	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00468	0.00601	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00436	0.0056	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—COMT—Parkinson's disease	0.00435	0.00559	CbGpPWpGaD
Dexbrompheniramine—KCNH2—Neuronal System—MAOA—Parkinson's disease	0.00432	0.00555	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00428	0.00549	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00395	0.00507	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.0039	0.00501	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00387	0.00497	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.00376	0.00482	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.00356	0.00457	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00346	0.00444	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00342	0.0044	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00338	0.00434	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00332	0.00427	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00332	0.00426	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00331	0.00425	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	0.00326	0.00418	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.0032	0.00411	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00312	0.00401	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	0.00303	0.00389	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.003	0.00385	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00293	0.00377	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.0029	0.00372	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.0029	0.00372	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00289	0.00371	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00284	0.00364	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	0.00284	0.00364	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00283	0.00364	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00274	0.00352	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00268	0.00345	CbGpPWpGaD
Dexbrompheniramine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00262	0.00337	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00259	0.00333	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00257	0.00331	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00248	0.00319	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00248	0.00319	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00241	0.0031	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00237	0.00304	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00235	0.00301	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00223	0.00287	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	0.0022	0.00283	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	0.00216	0.00277	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	0.00215	0.00276	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00212	0.00273	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	0.00209	0.00268	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00203	0.00261	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	0.00202	0.0026	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	0.00201	0.00258	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00199	0.00255	CbGpPWpGaD
Dexbrompheniramine—KCNH2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00195	0.0025	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	0.00193	0.00248	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	0.00189	0.00243	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	0.00189	0.00243	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00184	0.00236	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	0.00183	0.00235	CbGpPWpGaD
Dexbrompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00174	0.00223	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00171	0.0022	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	0.00168	0.00215	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	0.00168	0.00215	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	0.00167	0.00215	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	0.00155	0.002	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00153	0.00197	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	0.00151	0.00194	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00145	0.00187	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	0.00134	0.00172	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00132	0.0017	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00132	0.0017	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	0.00127	0.00163	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00126	0.00162	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00124	0.0016	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00122	0.00157	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00118	0.00152	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00115	0.00147	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	0.00114	0.00146	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	0.00113	0.00145	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	0.00111	0.00142	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.0011	0.00142	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PENK—Parkinson's disease	0.00108	0.00139	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MAG—Parkinson's disease	0.00108	0.00139	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	0.00107	0.00138	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00107	0.00137	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00107	0.00137	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.001	0.00129	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	0.000987	0.00127	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	0.00097	0.00125	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	0.00097	0.00125	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	0.000928	0.00119	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	0.000918	0.00118	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000855	0.0011	CbGpPWpGaD
Dexbrompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000814	0.00105	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	0.000805	0.00103	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	0.00078	0.001	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	0.000776	0.000997	CbGpPWpGaD
Dexbrompheniramine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000748	0.000961	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—INSR—Parkinson's disease	0.00072	0.000925	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—FGB—Parkinson's disease	0.000681	0.000874	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000679	0.000872	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	0.000677	0.00087	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	0.000667	0.000857	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	0.000654	0.00084	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	0.000633	0.000814	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000591	0.00076	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	0.000573	0.000736	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	0.000573	0.000736	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	0.00048	0.000617	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	0.000464	0.000596	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	0.000459	0.000589	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—NGF—Parkinson's disease	0.000421	0.000541	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	0.000401	0.000515	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—APOE—Parkinson's disease	0.000373	0.000479	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—INS—Parkinson's disease	0.000319	0.000409	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	0.000237	0.000305	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	0.000236	0.000303	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	0.000218	0.00028	CbGpPWpGaD
Dexbrompheniramine—HRH1—Signaling Pathways—IL6—Parkinson's disease	0.000139	0.000179	CbGpPWpGaD
